Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
MiniMed Group, Inc.
Market Cap
$560.00M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$554.88M
Earnings Per Share (EPS)
-1.31
TTM Avg
-1.22
3Y Avg
-1.34
5Y Avg
-1.08
Market Cap
$554.42M
Earnings Per Share (EPS)
-0.58
TTM Avg
-1.12
3Y Avg
-1.21
5Y Avg
-1.27
Market Cap
$554.29M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.57
3Y Avg
-1.57
5Y Avg
-1.57
Market Cap
$566.81M
Earnings Per Share (EPS)
2.13
TTM Avg
0.97
3Y Avg
0.08
5Y Avg
-0.20
Market Cap
$569.16M
Earnings Per Share (EPS)
-0.45
TTM Avg
0.12
3Y Avg
-0.31
5Y Avg
-0.31
Market Cap
$573.38M
Earnings Per Share (EPS)
-0.65
TTM Avg
-0.64
3Y Avg
-0.63
5Y Avg
-1.00
Market Cap
$542.04M
Earnings Per Share (EPS)
-1.28
TTM Avg
-4.16
3Y Avg
-4.49
5Y Avg
-4.33
Market Cap
$541.30M
Earnings Per Share (EPS)
0.01
TTM Avg
0.08
3Y Avg
-2.02
5Y Avg
-4.00
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $554.88M | -1.31 | -1.22 | -1.34 | -1.08 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $554.42M | -0.58 | -1.12 | -1.21 | -1.27 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $554.29M | N/A | -1.57 | -1.57 | -1.57 |
| CorMedix Inc. (CRMD)vs › | $566.81M | 2.13 | 0.97 | 0.08 | -0.20 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $569.16M | -0.45 | 0.12 | -0.31 | -0.31 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | -0.65 | -0.64 | -0.63 | -1.00 |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $542.04M | -1.28 | -4.16 | -4.49 | -4.33 |
| Delcath Systems, Inc. (DCTH)vs › | $541.30M | 0.01 | 0.08 | -2.02 | -4.00 |
| ProKidney Corp. (PROK)vs › | $536.32M | -0.57 | -0.57 | -0.87 | -0.89 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
